128 related articles for article (PubMed ID: 30032031)
1. Recombinant hepatitis C virus genotype 5a infectious cell culture systems expressing minimal JFH1 NS5B sequences permit polymerase inhibitor studies.
Humes D; Ramirez S; Jensen TB; Li YP; Gottwein JM; Bukh J
Virology; 2018 Sep; 522():177-192. PubMed ID: 30032031
[TBL] [Abstract][Full Text] [Related]
2. Adaptive Mutations Enhance Assembly and Cell-to-Cell Transmission of a High-Titer Hepatitis C Virus Genotype 5a Core-NS2 JFH1-Based Recombinant.
Mathiesen CK; Prentoe J; Meredith LW; Jensen TB; Krarup H; McKeating JA; Gottwein JM; Bukh J
J Virol; 2015 Aug; 89(15):7758-75. PubMed ID: 25995244
[TBL] [Abstract][Full Text] [Related]
3. Differential sensitivity of 5'UTR-NS5A recombinants of hepatitis C virus genotypes 1-6 to protease and NS5A inhibitors.
Li YP; Ramirez S; Humes D; Jensen SB; Gottwein JM; Bukh J
Gastroenterology; 2014 Mar; 146(3):812-821.e4. PubMed ID: 24262279
[TBL] [Abstract][Full Text] [Related]
4. Highly efficient JFH1-based cell-culture system for hepatitis C virus genotype 5a: failure of homologous neutralizing-antibody treatment to control infection.
Jensen TB; Gottwein JM; Scheel TK; Hoegh AM; Eugen-Olsen J; Bukh J
J Infect Dis; 2008 Dec; 198(12):1756-65. PubMed ID: 19032070
[TBL] [Abstract][Full Text] [Related]
5. HCV Genotype 6a Escape From and Resistance to Velpatasvir, Pibrentasvir, and Sofosbuvir in Robust Infectious Cell Culture Models.
Pham LV; Ramirez S; Gottwein JM; Fahnøe U; Li YP; Pedersen J; Bukh J
Gastroenterology; 2018 Jun; 154(8):2194-2208.e12. PubMed ID: 29454794
[TBL] [Abstract][Full Text] [Related]
6. Efficient infectious cell culture systems of the hepatitis C virus (HCV) prototype strains HCV-1 and H77.
Li YP; Ramirez S; Mikkelsen L; Bukh J
J Virol; 2015 Jan; 89(1):811-23. PubMed ID: 25355880
[TBL] [Abstract][Full Text] [Related]
7. Efficient culture adaptation of hepatitis C virus recombinants with genotype-specific core-NS2 by using previously identified mutations.
Scheel TK; Gottwein JM; Carlsen TH; Li YP; Jensen TB; Spengler U; Weis N; Bukh J
J Virol; 2011 Mar; 85(6):2891-906. PubMed ID: 21177811
[TBL] [Abstract][Full Text] [Related]
8. Development of full-length cell-culture infectious clone and subgenomic replicon for a genotype 3a isolate of hepatitis C virus.
Chen M; Xu Y; Li N; Yin P; Zhou Q; Feng S; Wu T; Wei L; Wang H; Fu Y; Li YP
J Gen Virol; 2021 Dec; 102(12):. PubMed ID: 34949310
[TBL] [Abstract][Full Text] [Related]
9. Robust HCV Genotype 3a Infectious Cell Culture System Permits Identification of Escape Variants With Resistance to Sofosbuvir.
Ramirez S; Mikkelsen LS; Gottwein JM; Bukh J
Gastroenterology; 2016 Nov; 151(5):973-985.e2. PubMed ID: 27453546
[TBL] [Abstract][Full Text] [Related]
10. Efficient Hepatitis C Virus Genotype 1b Core-NS5A Recombinants Permit Efficacy Testing of Protease and NS5A Inhibitors.
Pham LV; Ramirez S; Carlsen THR; Li YP; Gottwein JM; Bukh J
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28348150
[TBL] [Abstract][Full Text] [Related]
11. Highly efficient infectious cell culture of three hepatitis C virus genotype 2b strains and sensitivity to lead protease, nonstructural protein 5A, and polymerase inhibitors.
Ramirez S; Li YP; Jensen SB; Pedersen J; Gottwein JM; Bukh J
Hepatology; 2014 Feb; 59(2):395-407. PubMed ID: 23913364
[TBL] [Abstract][Full Text] [Related]
12. Adapted J6/JFH1-based Hepatitis C virus recombinants with genotype-specific NS4A show similar efficacies against lead protease inhibitors, alpha interferon, and a putative NS4A inhibitor.
Gottwein JM; Jensen SB; Serre SB; Ghanem L; Scheel TK; Jensen TB; Krarup H; Uzcategui N; Mikkelsen LS; Bukh J
Antimicrob Agents Chemother; 2013 Dec; 57(12):6034-49. PubMed ID: 24060868
[TBL] [Abstract][Full Text] [Related]
13. Current status and future development of infectious cell-culture models for the major genotypes of hepatitis C virus: Essential tools in testing of antivirals and emerging vaccine strategies.
Ramirez S; Bukh J
Antiviral Res; 2018 Oct; 158():264-287. PubMed ID: 30059723
[TBL] [Abstract][Full Text] [Related]
14. Development of an intergenotypic hepatitis C virus (HCV) cell culture method to assess antiviral susceptibilities and resistance development of HCV NS3 protease genes from HCV genotypes 1 to 6.
Imhof I; Simmonds P
J Virol; 2010 May; 84(9):4597-610. PubMed ID: 20164226
[TBL] [Abstract][Full Text] [Related]
15. Analysis of functional differences between hepatitis C virus NS5A of genotypes 1-7 in infectious cell culture systems.
Scheel TK; Prentoe J; Carlsen TH; Mikkelsen LS; Gottwein JM; Bukh J
PLoS Pathog; 2012; 8(5):e1002696. PubMed ID: 22654662
[TBL] [Abstract][Full Text] [Related]
16. Differential efficacy of protease inhibitors against HCV genotypes 2a, 3a, 5a, and 6a NS3/4A protease recombinant viruses.
Gottwein JM; Scheel TK; Jensen TB; Ghanem L; Bukh J
Gastroenterology; 2011 Sep; 141(3):1067-79. PubMed ID: 21699793
[TBL] [Abstract][Full Text] [Related]
17. A comprehensive structure-function comparison of hepatitis C virus strain JFH1 and J6 polymerases reveals a key residue stimulating replication in cell culture across genotypes.
Schmitt M; Scrima N; Radujkovic D; Caillet-Saguy C; Simister PC; Friebe P; Wicht O; Klein R; Bartenschlager R; Lohmann V; Bressanelli S
J Virol; 2011 Mar; 85(6):2565-81. PubMed ID: 21209117
[TBL] [Abstract][Full Text] [Related]
18. Replicons of a Rodent Hepatitis C Model Virus Permit Selection of Highly Permissive Cells.
Wolfisberg R; Holmbeck K; Nielsen L; Kapoor A; Rice CM; Bukh J; Scheel TKH
J Virol; 2019 Oct; 93(19):. PubMed ID: 31292246
[TBL] [Abstract][Full Text] [Related]
19. Highly efficient full-length hepatitis C virus genotype 1 (strain TN) infectious culture system.
Li YP; Ramirez S; Jensen SB; Purcell RH; Gottwein JM; Bukh J
Proc Natl Acad Sci U S A; 2012 Nov; 109(48):19757-62. PubMed ID: 23151512
[TBL] [Abstract][Full Text] [Related]
20. Combination treatment with hepatitis C virus protease and NS5A inhibitors is effective against recombinant genotype 1a, 2a, and 3a viruses.
Gottwein JM; Jensen SB; Li YP; Ghanem L; Scheel TK; Serre SB; Mikkelsen L; Bukh J
Antimicrob Agents Chemother; 2013 Mar; 57(3):1291-303. PubMed ID: 23274664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
